PCV54 To Evaluate the Medication Persistence of Direct Oral Anticoagulants Among Patients with Atrial Fibrillation, Hypertension, Diabetes and Hyperlipidemia

Atrial fibrillation (AF) is an independent risk factor of stroke, the most common disability in the United States. When used adequately, Direct oral anticoagulants (DOACs) substantially reduce the stroke events in patients with AF. Despite documented beneficial effects of anticoagulation therapy, poor persistence to DOACs is widely reported potentially due to the lack of frequent laboratory monitoring. Comorbidities frequently associated with AF include hypertension, diabetes, and hyperlipidemia, which further increase morbidity and mortality.
Source: Value in Health - Category: International Medicine & Public Health Authors: Source Type: research